A nurse is reviewing the electronic medical record of a client who has been taking famotidine for 6 months. Which of the following findings indicates the therapy has been ineffective?

Famotidine is an H2-receptor antagonist used to reduce gastric acid secretion in conditions such as gastroesophageal reflux disease, peptic ulcer disease, and heartburn. The therapeutic goal is relief of acid-related symptoms including heartburn. If a client who has been taking famotidine for six months continues to experience heartburn, this indicates the medication has not achieved its intended therapeutic effect. Ongoing heartburn after six months of treatment signals treatment failure and warrants reassessment of the regimen or consideration of alternative therapy such as a proton pump inhibitor. Muscle cramps, tinnitus, and fever are not among the therapeutic goals of famotidine, nor are they expected effects of the drug's mechanism of action in the GI tract. Tinnitus can be associated with certain medications such as salicylates or aminoglycosides, but is not a marker of famotidine efficacy. Fever may signal infection or other unrelated illness. Muscle cramps could reflect electrolyte issues unrelated to H2 blocker therapy. Only the persistence of heartburn directly reflects that the medication has failed to suppress acid secretion adequately, making it the correct answer indicating therapeutic ineffectiveness.